Innovent And Etana Get Indonesian Bevacizumab Nod

Partners Receive Approval For Bevagen Biosimilar To Avastin From Indonesia’s BPOM

 
• By Dave Wallace

Innovent and marketing partner Etana have celebrated an approval for their Bevagen bevacizumab biosimilar from the Indonesian regulator.

Indonesia flag tick check pen
Indonesia’s medicines agency has approved the biosimilar • Source: Shutterstock

More from Biosimilars

More from Products